Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.85 USD | -2.78% | -3.13% | +157.41% |
05-17 | Vera Therapeutics Insider Sold Shares Worth $1,304,435, According to a Recent SEC Filing | MT |
05-10 | Wedbush Adjusts Vera Therapeutics' PT to $32 From $34, Keeps Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+157.41% | 2.24B | |
+42.00% | 54.04B | |
+43.57% | 41.96B | |
-1.16% | 41.92B | |
-7.59% | 28.35B | |
+12.18% | 26.35B | |
-22.56% | 19B | |
+7.80% | 13B | |
+28.68% | 12.28B | |
+25.26% | 12.19B |
- Stock Market
- Equities
- VERA Stock
- News Vera Therapeutics, Inc.
- Wedbush Raises Vera Therapeutics' Price Target to $9 From $6, Keeps Neutral Rating